145 related articles for article (PubMed ID: 20554327)
1. Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challenge.
Pal S; Tatarenkova O; de la Maza LM
J Reprod Immunol; 2010 Nov; 86(2):151-7. PubMed ID: 20554327
[TBL] [Abstract][Full Text] [Related]
2. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
Pal S; Davis HL; Peterson EM; de la Maza LM
Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis.
Pal S; Peterson EM; de la Maza LM
Vaccine; 2005 Nov; 23(46-47):5351-8. PubMed ID: 16085340
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge.
Pal S; Peterson EM; de la Maza LM
Infect Immun; 1996 Dec; 64(12):5341-8. PubMed ID: 8945586
[TBL] [Abstract][Full Text] [Related]
5. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
6. A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males.
Pal S; Sarcon AK; de la Maza LM
Vaccine; 2010 Nov; 28(48):7606-12. PubMed ID: 20920574
[TBL] [Abstract][Full Text] [Related]
7. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.
Ralli-Jain P; Tifrea D; Cheng C; Pal S; de la Maza LM
Vaccine; 2010 Nov; 28(48):7659-66. PubMed ID: 20875490
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of T-cell mediated protection in newborn mice against a Chlamydia infection.
Pal S; de la Maza LM
Microbes Infect; 2013; 15(8-9):607-14. PubMed ID: 23644176
[TBL] [Abstract][Full Text] [Related]
11. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
[TBL] [Abstract][Full Text] [Related]
12. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.
Pal S; Fielder TJ; Peterson EM; de la Maza LM
Infect Immun; 1994 Aug; 62(8):3354-62. PubMed ID: 8039906
[TBL] [Abstract][Full Text] [Related]
13. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.
Pal S; Peterson EM; de la Maza LM
Infect Immun; 2005 Dec; 73(12):8153-60. PubMed ID: 16299310
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin.
Cheng C; Bettahi I; Cruz-Fisher MI; Pal S; Jain P; Jia Z; Holmgren J; Harandi AM; de la Maza LM
Vaccine; 2009 Oct; 27(44):6239-46. PubMed ID: 19686693
[TBL] [Abstract][Full Text] [Related]
16. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
18. A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.
Cheng C; Jain P; Bettahi I; Pal S; Tifrea D; de la Maza LM
Vaccine; 2011 Sep; 29(38):6641-9. PubMed ID: 21742006
[TBL] [Abstract][Full Text] [Related]
19. Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity.
Lu H; Yang X; Takeda K; Zhang D; Fan Y; Luo M; Shen C; Wang S; Akira S; Brunham RC
Mol Med; 2000 Jul; 6(7):604-12. PubMed ID: 10997341
[TBL] [Abstract][Full Text] [Related]
20. Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice.
Pal S; Tifrea DF; Zhong G; de la Maza LM
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
